Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TriPharm Services operated as a CDMO focused on sterile fill-finish for parenteral drugs, with a facility in Morrisville, North Carolina, equipped for syringes, vials, and isolators. It was acquired by Alcami, expanding Alcami's capabilities in prefilled syringes and isolator tech. Backed by Ampersand Capital Partners, it planned expansions like lyophilisation but is no longer independent. As a service provider, it had no clinical pipeline, modalities, or therapeutic focus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TriPharm Services.